Oxaliplatin NDC 72266-162

Product information

Brand name (proprietary)

Oxaliplatin

Generic name (nonproprietary)

oxaliplatin

Active ingredients

Oxaliplatin — 5 mg/mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

FOSUN PHARMA USA INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207325

Marketing start

Mar 30, 2020

Listing expires

Dec 31, 2026

Other FDA classes

Platinum-containing Compounds (EXT)

Identifiers

Product ID 72266-162_2b48f7c2-8c48-6b82-e063-6394a90a3bafSPL ID 2b48f7c2-8c48-6b82-e063-6394a90a3bafSPL set ID fad0f147-6595-4412-87a7-2afca0192a96RxCUI 1736776, 1736781UNII 04ZR38536JUPC 0372266161017, 0372266162014

Pharmacologic class

Platinum-based Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472266016201 followed by a unit qualifier and the quantity Copy

Package 72266-0162-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 207325

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.